Refine
Estimated Years 2000-2009Clear
2,481 results foundRefine Search
AR -03tpD August 30, 2000 Mr.
Document image
refid# XOqJKOLB95G0KqXr2bQ2o6dKd1 page
/)/U 3 - o?
Document imageDocument imageDocument imageDocument image
refid# v6xeD2XoyBRm04rv5LKpbYMyb8 pages
sffl ORIGINAL A-R AA6 _ 0 3 7 7 JM Spedaltjr Material 3M Center S t Paul.
Document imageDocument image
refid# 5X09egN1NVRb2BpqeROgKzLN2 pages
x NflK* 532 PRO'*'1' ^ R <9 ^ 3 7 Lf AR.27.G_ I0<?
Document imageDocument imageDocument imageDocument image
refid# ZJpJEZKrbo7yoGExpoKZQqxLp82 pages
RECEIVED A fu a - /s Telomer Research Program 1200 South Hayes Street Arlington, Virginia 22202-5050 Tet (703)413-1100 45264 Fac (703)4136111 Clariant February 14, 2003 Mary F.
Document imageDocument imageDocument imageDocument image
refid# EqjK61O7b3MQ2KBEEQoBYvb2n32 pages
>*224-/SO P rsn 8ema/d - on 10/04/2001 08 26 AM cc SvOiect rhjrru^jtPv'fcncorp com swashburn@envtrencorD com M Am 8'<H*v.'
Document image
refid# p48Y3m5dXNL2dLBw6OwQ1JED1 page
AR226-1753 PFOS: A REPRODUCTION STUDY WITH THE NORTHERN BOBWHITE FINAL REPORT WILDLIFE INTERNATIONAL, LTD.
Document imageDocument imageDocument imageDocument image
refid# 4a4XBYZLVvpEOV2p3n6G8RaoR196 pages
Toxicological Summary PFOS Dietary Chronic Pilot Reproductive Study: Northern Bobwhite Test Substance: Perfluorooctanesulfonate (PFOS) Structure: 1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8heptadecafluoro-potassium salt.
Document imageDocument imageDocument imageDocument image
refid# Yjwwve4Mx0g6n0ogp89ZbryMK12 pages
BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE April 2004 Click on Study Title to View Report April 16, 2004 Butenhoff, J.L., et al., "Characterization of Risk for General Population Exposure to Perfluorooctanoate," Regulatory Toxicology and Pharmacology 39 (2004) 363-380, April 16, 2004
Document image
refid# O3Q36R9QGYdjpw724GDyK5RxM1 page
Larry R.
Document imageDocument imageDocument image
refid# jNnmbQK0vxa580rQ1Nk1py1N93 pages
C harles J Zarzecki 02/24/2003 02:43 PM To: Catherine A Barton/AE/DuPont co: Subject: Slid e s Cathie, Here they are.
Document imageDocument imageDocument imageDocument image
refid# r6NYb24eE3vB0NZ7E57ZZLq4a6 pages
AR226-2480 fr DuPont WaabmgttmWofo P,D.Bo*'21: patesbW9, W 2B1DZ-1211 October 4, 2000 Mr.
Document imageDocument imageDocument imageDocument image
refid# 2j6GBQgLEVME9YGyyDdoy4K0g8 pages
AR226-2496 .Analysis Report LancasterLaboratories f Wh&Gquaiitykasckrm a n a ly tic a l r e su l t s Prqrwed foP CRO-RLDuPomde Nemours & Co Barley Mill Plaza, Bldg. 27 Lancaster race & Route 141 WUrmogtoilLB 19805 302-992^76?
Document imageDocument imageDocument imageDocument image
refid# rpEO1xJNQVd7eqkL3EmBDeD2G4 pages
Katherine E.
Document imageDocument image
refid# ErkywkKLqmVYbemyZ4z5J8mx2 pages
AR226-3166 ____________________ ____________________________ DuPont-4182 TRADE SECRET Study Title H-24159: Biopersistence Screening 10-Dose Oral Gavage Study in Rats Laboratory Project ID: DuPont-4182 Author: Carol Finlay, B.A.
Document imageDocument imageDocument imageDocument image
refid# baowg539rg510nxwezmrZx6kZ93 pages